发明名称 |
Methods of Treating Hepatic Fibrosis and Associated Diseases by Regulating Rev-ERB Activity |
摘要 |
The present invention is directed to compositions and associated methods for treatment, prevention, amelioration, and/or delaying the onset of hepatic fibrosis and/or associated diseases. The methods preferably involve regulating at least one of Rev-erbα expression, activity, and subcellular localization. In particular, certain embodiments of the present invention relate to compositions and methods of using a Rev-erb-modulating agent (REMA) for the treatment or prevention of hepatic fibrosis and/or associated diseases. Preferably, the amount of a REMA administered comprises a quantity sufficient to modulate at least one of Rev-erbα expression, activity, and subcellular localization and reduce the activation of hepatic stellate cells (HSCs). |
申请公布号 |
US2015328186(A1) |
申请公布日期 |
2015.11.19 |
申请号 |
US201314651413 |
申请日期 |
2013.12.12 |
申请人 |
The Charlotte-Mecklenburg Hospital Authority d/b/a Carolinas Healthcare System |
发明人 |
Li Ting;Schrum Laura |
分类号 |
A61K31/4025;A61K45/06;A61K47/48 |
主分类号 |
A61K31/4025 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating, preventing, ameliorating, and/or delaying the onset of liver fibrosis and related pathologies in a mammal in need thereof, comprising: administering a composition comprising a therapeutically effective amount of one or more Rev-erb—modulating agents (REMA) to the mammal, wherein said one or more REMA modulates at least one of Rev-erbα expression, activity, and subcellular localization in at least a portion of the mammal's hepatic stellate cells (HSCs). |
地址 |
Charlotte NC US |